Immunocompromised

IsoPlexis joins MediMergent, CCBD for COVID-19 study

The large multisite study will focus on the functionality of immune cells and their role in prevention of breakthrough COVID-19 infections in immunocompromised patients following administration of AstraZeneca's AZD7442 IM or IV antibody combination.

September 5, 2022

CoVac-1 vaccine shows promise for immunocompromised patients

Walz's team used their expertise with cancer therapeutics to develop a vaccine that induces T cells in immunocompromised patients who do not produce an adequate immune response to other vaccines.

May 1, 2022

Karius raises $165M for infectious disease blood test

The Redwood City, CA-based company markets the Karius test, a next-generation sequencing and artificial intelligence-powered option designed to screen blood for 1,000 pathogens, including bacteria, fungi, DNA viruses, and parasites. The test is being positioned for a range of applications, including complicated pneumonia, infections in immunocompromised patients, and endocarditis.

February 24, 2020

Roche launches adenovirus PCR test in Europe

Transplant patients are immunocompromised and at risk for developing infections, including from adenoviruses. Adenoviruses can lead to a range of conditions -- such as conjunctivitis, gastroenteritis, hepatitis, and pneumonia -- that cause complications and organ rejection in transplant patients.

January 14, 2020

Most Popular

Genetic causes identified for three rare diseases

Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease

SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests

Duke University researchers discover biomarkers may identify early pancreatic cancer risk

Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition

Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu